First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study
Cristina Carbonell(University of California, Irvine), Melany Pestaña-Fernández(Bellvitge University Hospital), Nerea Iniesta-Arandia(Hospital Clínic de Barcelona), Luís Sáez-Comet(Hospital Universitario Miguel Servet), Pablo Segovia-Alonso(Complejo Hospitalario de Salamanca), Bernard Mari(Institut de Pharmacologie Moléculaire et Cellulaire), Eduardo Callejas Moraga(Hospital Universitario Fundación Alcorcón), Xavier Pla-Salas(Universitat de Vic - Universitat Central de Catalunya), D. Colunga(Universitat Internacional de Catalunya), José Antonio Vargas‐Hitos(Hospital Universitario Virgen de las Nieves), Xavier Corbella(Bellvitge University Hospital), Manuel Ruiz Muñoz(Hospital Universitario Fundación Alcorcón), N. Iniesta(Hospital Universitario Fundación Alcorcón), Gerard Espinosa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Manuel Pestana(Hospital de São João), M. Freire(University Hospital Complex Of Vigo), Ana Belén Madroñero-Vuelta(Hospital Universitario Fundación Alcorcón), Enrique Calvo(Institute of Agrifood Research and Technology), Vicent Fonollosa‐Pla(Vall d'Hebron Hospital Universitari), Norberto Ortego‐Centeno, Francisco José García Hernández(Hospital Universitario Virgen del Rocío), Adela Marín Ballvé(Complejo Hospitalario de Salamanca), Juan José Ríos Blanco(Hospital Universitario La Paz), Mónica Rodríguez‐Carballeira(Bellvitge University Hospital), Dolores Colunga-Argüelles(Hospital Universitario Central de Asturias), Alfredo Castillo(Vall d'Hebron Hospital Universitari), Carmen Pilar Simeón‐Aznar(Vall d'Hebron Hospital Universitari), Carles Tolosa-Vilella(Corporació Sanitària Parc Taulí), Luis Trapiella-Martínez(Hospital Clínic de Barcelona), Ana Marín(Instituto de Investigación Biosanitaria de Granada), Rocío González León(Vall d'Hebron Hospital Universitari), Ana Belén Madroñero(Hospital Clínico Universitario Lozano Blesa), Manuel Rubio‐Rivas(Bellvitge University Hospital), Mercedes Pérez Conesa(Bellvitge University Hospital), R. Lorenzo(Hospital General San Jorge), M. V. Egurbide(Complejo Hospitalario de Salamanca), María Jesús Castillo‐Palma(Hospital Universitario Miguel Servet), María Victoria Egurbide-Arberas(Hospital de Cruces), María Jesús Castillo(Hospital Universitari i Politècnic La Fe)
Cited by 47
Related Papers
miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity
|Cell Death and Differentiation|2010|414
miR-199a-5p Is Upregulated during Fibrogenic Response to Tissue Injury and Mediates TGFbeta-Induced Lung Fibroblast Activation by Targeting Caveolin-1
|PLoS Genetics|2013|259
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
|Nature Communications|2021|166
A loss-of-function variant of PTPN22 is associated with reduced risk of systemic lupus erythematosus
|Human Molecular Genetics|2008|124
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021
|Emerging infectious diseases|2023|81